Aaron Royston's Net Worth

$0

Estimate Recalculated Nov 11, 2024 01:47PM EST

Who is Aaron Royston

Aaron Royston does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ventyx Biosciences, Inc., Akero Therapeutics, Inc., Menlo Therapeutics Inc., Elevation Oncology, Inc., and RayzeBio, Inc..

SEC CIK

Aaron Royston's CIK is 0001727703

Past Insider Trading and Trends

2022 was Aaron Royston's most active year for acquiring shares with 2 total transactions. Aaron Royston's most active month to acquire stocks was the month of May. 2019 saw Aaron Royston paying a total of $0.00 for 22,500 shares, this is the most they've acquired in one year.

No data available

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Elevation Oncology, Inc.

Investor
Updated May 27, 2022
May 25
Jun 29
Showing 3 results

Ventyx Biosciences, Inc.

Investor
Updated Apr 26, 2023
Form 4/A21.83KJun 09
Form 3/A
13.30KJun 09
Oct 25
1.01M
Showing 5 results

Akero Therapeutics, Inc.

Investor
Updated Jun 25, 2019
Jun 24
Showing 2 results

Menlo Therapeutics Inc.

Investor
Updated Aug 08, 2019
Form 4/A22.50KJun 25
Showing 2 results

RayzeBio, Inc.

Investor
Updated Sep 14, 2023
Showing 1 results